Skip to main content

What the FDA labels say about taking them together

Diltiazem and sotalol

Sotalol's FDA label of December 16, 2024 names diltiazem in its drug interactions section; the diltiazem labels PlainMeds reads (4) do not name sotalol. The sotalol label: “Digitalis glycosides, diltiazem, verapamil, and beta-blockers slow atrioventricular conduction and decrease heart rate.”

Check it at the source: the diltiazem FDA label on DailyMed (effective August 7, 2026, Bausch Health US, LLC); the sotalol FDA label on DailyMed (effective December 16, 2024, Legacy Pharma USA, Inc.).

What does the diltiazem label say about sotalol?

Diltiazem's label (effective August 7, 2026) and its 3 other brand-application labels do not name sotalol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (TIAZAC EXTENDED RELEASE), Bausch Health US, LLC, effective August 7, 2026 (SPL set c567fe7e-887e-4291-a0d1-2dd3f25cbf25), via openFDA; the full label on DailyMed

What does the sotalol label say about diltiazem?

Sotalol label, drug interactions

Digitalis glycosides, diltiazem, verapamil, and beta-blockers slow atrioventricular conduction and decrease heart rate.

Source: FDA drug label (BETAPACE), Legacy Pharma USA, Inc., effective December 16, 2024 (SPL set a6a7702f-36c9-45db-b640-453dc324baee), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

50Diltiazem generic labelers
18Sotalol generic labelers
DiltiazemSotalol
Labeled forHigh blood pressure, Angina, Atrial fibrillationAtrial fibrillation
Boxed warningNoYes
Pharmacy cost (NADAC)$0.144 per capsule 24h ER(cd) 120 mg capsule$0.0707 per tablet 80 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?